These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2555146)

  • 1. Pseudohypoparathyroidism showing positive phosphaturic and negative cyclic AMP excretion response to parathyroid hormone.
    Higashi K; Honda K; Morita M; Umeda T; Shimada T; Kimura K; Shido T; Arita I; Sato T
    Endocrinol Jpn; 1989 Aug; 36(4):465-9. PubMed ID: 2555146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urinary phosphate and cyclic adenosine monophosphate response to intravenous administration of synthetic human parathyroid hormone-(1-34) in idiopathic hypoparathyroidism, pseudohypoparathyroidism, pseudopseudohypoparathyroidism and normal subjects].
    Fukami T; Fujita T; Yoshimoto Y; Fukase M; Imai Y; Sakaguchi K; Ogata E; Furukawa Y; Suzuki H; Takebe K
    Nihon Naibunpi Gakkai Zasshi; 1984 Mar; 60(3):159-70. PubMed ID: 6090236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of pseudohypoparathyroidism (PHP) type II associated with Bartter's syndrome--restoration of phosphaturic response to parathyroid hormone (PTH) by treatment for hypopotassemia].
    Bando Y; Miyakoshi H; Nagaoka T; Ohsawa K; Kobayashi K
    Nihon Naibunpi Gakkai Zasshi; 1992 Jul; 68(7):676-87. PubMed ID: 1516722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of resistance to the phosphaturic effect of the parathyroid hormone in the hamster.
    Knox FG; Preiss J; Kim JK; Dousa TP
    J Clin Invest; 1977 Apr; 59(4):675-83. PubMed ID: 14974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of calcium administration on renal responsiveness to parathyroid hormone in pseudohypoparathyroidism type I and II -- in comparison with normals, idiopathic and surgical hypoparathyroidism.
    Yamada K; Tamura Y; Yamamoto M; Kumagai A
    Endocrinol Jpn; 1979 Apr; 26(2):147-57. PubMed ID: 225161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of pseudohypoparathyroidism Type I & Type II (author's transl)].
    Yamada K; Tamura Y; Yamamoto M; Kumagai A
    Nihon Naibunpi Gakkai Zasshi; 1976 Oct; 52(10):983-96. PubMed ID: 190053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the attainment of normocalcemia in patients with pseudohypoparathyroidism.
    Breslau NA; Notman DD; Canterbury JM; Moses AM
    Am J Med; 1980 Jun; 68(6):856-60. PubMed ID: 6247909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urinary excretion of cAMP after PTH injection in patients with hypohyperparathyroidism (author's transl)].
    González Macías J; Gertner JM; Brenton DB
    Med Clin (Barc); 1979 Oct; 73(6):219-21. PubMed ID: 232737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic human parathyroid hormone-(1-34) for the study of pseudohypoparathyroidism.
    Mallette LE; Kirkland JL; Gagel RF; Law WM; Heath H
    J Clin Endocrinol Metab; 1988 Nov; 67(5):964-72. PubMed ID: 2846629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chlorpropamide on renal response to parathyroid hormone in normal subjects and in patients with hypoparathyroidism and pseudohypoparathyroidism.
    Coulson R; Moses AM
    J Pharmacol Exp Ther; 1975 Sep; 194(3):603-13. PubMed ID: 169346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium potentiates the cyclic nucleotide and phosphaturic response to parathyroid hormone infusion.
    Bikle DD; Herman RH
    J Clin Endocrinol Metab; 1983 Jan; 56(1):11-7. PubMed ID: 6292254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal adenylate cyclase and the interrelationship between parathyroid hormone and vitamin D in the regulation of urinary phosphate and adenosine cyclic 3',5'-monophosphate excretion.
    Forte LR; Nickols GA; Anast CS
    J Clin Invest; 1976 Mar; 57(3):559-68. PubMed ID: 175088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary hyperparathyroidism with 1,25-dihydroxyvitamin D deficiency and pseudohypoparathyroidism in childhood: relationship between plasma 1,25-dihydroxyvitamin D and parathyroid hormone levels and urinary cyclic AMP response to exogenous PTH.
    Seino Y; Ishida M; Yamaoka K; Shimotsuji T; Ishii T; Yabuuchi H; Fukase M; Fujita T
    Eur J Pediatr; 1981 Feb; 135(3):267-71. PubMed ID: 6262082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of parathyroid hormone on 1,25-dihydroxyvitamin D formation in type I pseudohypoparathyroidism.
    Aksnes L; Aarskog D
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1223-6. PubMed ID: 6255001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3.
    Gloor HJ; Bonjour JP; Caverzasio J; Fleisch H
    J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The diagnostic value of the determination of cyclic 3',5'-adenosine monophosphate (cAMP) in urine].
    Gennari C; Galli M; Montagnani M; D'Amore I
    Quad Sclavo Diagn; 1976 Mar; 12(1):15-38. PubMed ID: 190633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of native parathyroid hormone and synthetic biologically active fragments in pseudohypoparathyroidism and hypoparathyroidism.
    Neer RM; Tregear GW; Potts JT
    J Clin Endocrinol Metab; 1977 Feb; 44(2):420-3. PubMed ID: 190258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased urinary phosphate excretion in pseudohypoparathyroidism type II with long-term treatment with phosphodiesterase inhibitor.
    Mano T; Uchimura K; Hayashi R; Kobahashi T; Fujiwara K; Makino M; Kakizawa H; Nagata M; Nakai A; Wada M; Nagasaka A; Itoh M
    Horm Metab Res; 1999 Nov; 31(11):602-5. PubMed ID: 10598827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
    Stögmann W
    Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of plasma 1,25-dihydroxyvitamin D in the human PTH(1-34) infusion test: an improved index for the diagnosis of idiopathic hypoparathyroidism and pseudohypoparathyroidism.
    Miura R; Yumita S; Yoshinaga K; Furukawa Y
    Calcif Tissue Int; 1990 May; 46(5):309-13. PubMed ID: 2159833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.